No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.

No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
复制标题

DOI:
10.1093/infdis/jiaa593
复制
发表时间:
2020-11-13
期刊:
The Journal of infectious diseases
影响因子:
--
通讯作者:
Kreil TR
Kreil TR
中科院分区:
其他
文献类型:
--
作者:
Schwaiger J;Karbiener M;Aberham C;Farcet MR;Kreil TR

文献摘要

参考文献

被引文献

相似文献

2020年SARS-CoV-2大流行是由一种人畜共患冠状病毒传播给人类引起的,与早期的事件类似。其他季节性传播的冠状病毒是否会在人体内诱导针对新物种的交叉反应性,甚至可能是交叉中和性抗体尚不清楚。这一问题对免疫缺陷者尤其重要,因为他们的健康取决于免疫球蛋白制剂的治疗,而免疫球蛋白制剂需要含有针对其环境中病原体的中和抗体。对54种从欧洲和美国收集的血浆中生产的静脉注射免疫球蛋白制剂进行了测试,证实了对季节性冠状病毒的高度中和作用;然而,没有观察到对新型SARS-CoV-2的交叉中和作用。
The 2020 SARS-CoV-2 pandemic is caused by a zoonotic coronavirus transmitted to humans, similar to earlier events. Whether the other, seasonally circulating coronaviruses induce cross-reactive, potentially even cross-neutralizing, antibodies to the new species in humans is unclear. The question is particularly relevant for people with immune deficiencies, as their health depends on treatment with immunoglobulin preparations that need to contain neutralizing antibodies against the pathogens in their environment. Testing 54 intravenous immunoglobulin preparations, produced from plasma collected in Europe and the United States, confirmed highly potent neutralization of a seasonal coronavirus; however, no cross-neutralization of the new SARS-CoV-2 was seen.
DOI: 10.1038/s41591-020-0913-5
发表时间: 2020-07
期刊: Nature medicine
影响因子: 82.9
作者:
Amanat F;Stadlbauer D;Strohmeier S;Nguyen THO;Chromikova V;McMahon M;Jiang K;Arunkumar GA;Jurczyszak D;Polanco J;Bermudez-Gonzalez M;Kleiner G;Aydillo T;Miorin L;Fierer DS;Lugo LA;Kojic EM;Stoever J;Liu STH;Cunningham-Rundles C;Felgner PL;Moran T;García-Sastre A;Caplivski D;Cheng AC;Kedzierska K;Vapalahti O;Hepojoki JM;Simon V;Krammer F
通讯作者: Krammer F
DOI: 10.1128/aac.01598-05
发表时间: 2006-06-01
影响因子: 4.9
作者:
Pyrc, Krzysztof;Bosch, Berend Jan;van der Hoek, Lia
通讯作者: van der Hoek, Lia
DOI: 10.1093/infdis/jiaa185
发表时间: 2020-07-01
影响因子: 6.4
作者:
Nickbakhsh, Sema;Ho, Antonia;Murcia, Pablo R.
通讯作者: Murcia, Pablo R.
DOI: 10.1002/jmv.25715
发表时间: 2020-03-03
影响因子: 12.7
作者:
Gorse, Geoffrey J.;Donovan, Mary M.;Patel, Gira B.
通讯作者: Patel, Gira B.
DOI: 10.1016/j.vaccine.2019.04.022
发表时间: 2019-05-27
期刊: VACCINE
影响因子: 5.5
作者:
Farcet, Maria R.;Karbiener, Michael;Kreil, Thomas R.
通讯作者: Kreil, Thomas R.